UK optometrists given prescribing powers

Article

Optometrists in the UK will soon be given the power to prescribe drugs for conditions such as dry eye.

Optometrists in the UK will soon be given the power to prescribe drugs for conditions such as dry eye.

Some optometrists are already able to write prescriptions but they are required to have them signed off by a doctor. The new legislation will allow them to prescribe drugs for dry eye and conjunctivitis without a doctor having to be involved, once they have undergone additional training.

Chairman of the British Medical Association's ophthalmic group committee, Rhod Daniel, believes that it is a good move that will reduce non-sight threatening referrals to eye hospitals and free up general practitioners' time for more urgent matters. However, he has also warned that it must be carefully monitored to ensure patient safety takes precedence over convenience and economic concerns.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.